US Patent:
20110160225, Jun 30, 2011
Inventors:
Mark G. Currie - Sterling MA, US
John Jeffrey Talley - Somerville MA, US
Brian Cali - Arlington MA, US
Assignee:
IRONWOOD PHARMACEUTICALS, INC. - Cambridge MA
International Classification:
A61K 31/496
C07C 203/04
A61K 31/21
A61K 31/24
C07C 69/716
A61K 31/216
C07D 263/28
A61K 31/421
C07D 207/22
A61K 31/40
C07D 403/04
C07D 239/42
A61K 31/505
C07D 209/24
A61K 31/405
C07D 403/12
A61K 31/41
C07D 403/14
A61P 3/06
A61P 3/10
US Classification:
51425405, 558488, 514506, 514509, 558482, 514534, 560 52, 514545, 548233, 514377, 548558, 514426, 544370, 544297, 514275, 548494, 514415, 548251, 514381
Abstract:
Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more fibric acid or statin derivative compositions alone or in combination with one or more lipid altering agents and/or PDE inhibitors.